Anthem Blue Cross Blue Shield of Colorado prior authorization, page 50

CPT code lookup

Each row is one code from the public prior authorization list. The description is the procedure or service name on that source row. This is not a coverage decision.

Prior authorization codes

Prior authorization codes
CodeDescriptionSource
0075UCYP2D6 (cytochrome P450, family 2, subfamily D, polypeptide 6) (eg, drug metabolism) gene analysis, targeted sequence analysis (ie, 5 gene duplication/multiplication) (List seColorado Prior Authorization List, Pg 119 Original policy
0076UCYP2D6 (cytochrome P450, family 2, subfamily D, polypeptide 6) (eg, drug metabolism) gene analysis, targeted sequence analysis (ie, 3 gene duplication/ multiplication) (List sColorado Prior Authorization List, Pg 119 Original policy
0078UPain management (opioid-use disorder) genotyping panel, 16 common variants (ie, ABCB1, COMT, DAT1, DBH, DOR, DRD1, DRD2, DRD4, GABA, GAL, HTR2A, HTTLPR, MTHFR, MUOR, OPRK1, OPColorado Prior Authorization List, Pg 119 Original policy
0079UComparative DNA analysis using multiple selected single-nucleotide polymorphisms(SNPs), urine and buccal DNA, for specimen identity verificationColorado Prior Authorization List, Pg 119 Original policy
0080UOncology (lung), mass spectrometric analysis of galectin-3-binding protein and scavenger receptor cysteine-rich type 1 protein M130, with five clinical risk factors (age, smokColorado Prior Authorization List, Pg 119 Original policy
0085TBreath test for heart transplant rejectionColorado Prior Authorization List, Pg 119 Original policy
0087UCardiology (heart transplant), mRNA gene expression profiling by microarray of 1283 genes, transplant biopsy tissue, allograft rejection and injury algorithm reported as a proColorado Prior Authorization List, Pg 119 Original policy
0088UTransplantation medicine (kidney allograft rejection), microarray gene expression profiling of 1494 genes, utilizing transplant biopsy tissue, algorithm reported as a probabilColorado Prior Authorization List, Pg 119 Original policy
0089UOncology (melanoma), gene expression profiling by RTqPCR, PRAME and LINC00518, superficial collection using adhesive patch(es)Colorado Prior Authorization List, Pg 119 Original policy
0090UOncology (cutaneous melanoma), mRNA gene expression profiling by RT-PCR of 23 genes (14 content and 9 housekeeping), utilizing formalin-fixed paraffin- embedded (FFPE) tissueColorado Prior Authorization List, Pg 119 Original policy
0092UOncology (lung), three protein biomarkers, immunoassay using magnetic nanosensor technology, plasma, algorithm reported as risk score for likelihood of malignancyColorado Prior Authorization List, Pg 119 Original policy
0094UGenome (eg, unexplained constitutional or heritable disorder or syndrome), rapid sequence analysisColorado Prior Authorization List, Pg 119 Original policy
0095TRemoval of total disc arthroplasty (artificial disc), anterior approach, each additional interspace, cervical (List separately in addition to code for primary procedure)Colorado Prior Authorization List, Pg 119 Original policy
0098TRevision including replacement of total disc arthroplasty (artificial disc), anterior approach, each additional interspace, cervical (List separately in addition to code for pColorado Prior Authorization List, Pg 119 Original policy
0100TPlacement of a subconjunctival retinal prosthesis receiver and pulse generator, and implantation of intra-ocular retinal electrode array, with vitrectomyColorado Prior Authorization List, Pg 119 Original policy
0101TExtracorporeal shock wave involving musculoskeletal system, not otherwise specifiedColorado Prior Authorization List, Pg 119 Original policy
0101UHereditary colon cancer disorders (eg, Lynch syndrome, PTEN hamartoma syndrome, Cowden syndrome, familial adenomatosis polyposis), genomic sequence analysis panel utilizing aColorado Prior Authorization List, Pg 119 Original policy
0102TExtracorporeal shock wave performed by a physician, requiring anesthesia other than local, and involving the lateral humeral epicondyleColorado Prior Authorization List, Pg 119 Original policy
0102UHereditary breast cancer-related disorders (eg, hereditary breast cancer, hereditary ovarian cancer, hereditary endometrial cancer), genomic sequence analysis panel utilizingColorado Prior Authorization List, Pg 119 Original policy
0103UHereditary ovarian cancer (eg, hereditary ovarian cancer, hereditary endometrial cancer), genomic sequence analysis panel utilizing a combination of NGS, Sanger, MLPA, and arrColorado Prior Authorization List, Pg 119 Original policy
0105UNephrology (chronic kidney disease), multiplex electrochemiluminescent immunoassay (ECLIA) of tumor necrosis factor receptor 1A, receptor superfamily 2 (TNFR1, TNFR2), and kidColorado Prior Authorization List, Pg 120 Original policy
0106TQST TST-EXT; TOUCH PRESS LG DIAM SENSATIONColorado Prior Authorization List, Pg 120 Original policy
0107TQST TST-EXT; VIBRATION LG DIAM FIBER SENSATIONColorado Prior Authorization List, Pg 120 Original policy
0108TQST-EXT; COOL SM NRV FIBR SENSATION&HYPERALGESIAColorado Prior Authorization List, Pg 120 Original policy
0108UGastroenterology (Barrett's esophagus), whole slide-digital imaging, including morphometric analysis, computer-assisted quantitative immunolableing of 9 protein biomarkers (p1Colorado Prior Authorization List, Pg 120 Original policy
0109TQST-EXT;HEAT-PAIN SM NRV FIBR SENSATN&HYPRALGSIAColorado Prior Authorization List, Pg 120 Original policy
0110TQST TST-EXT; OTHER STIMULI ASSESS SENSATIONColorado Prior Authorization List, Pg 120 Original policy
0111UOncology (colon cancer), targeted KRAS (codons 12, 13, and 61) and NRAS (codons 12, 13, and 61) gene analysis utilizing formalin-fixed paraffin-embedded tissueColorado Prior Authorization List, Pg 120 Original policy
0112UInfectious agent detection and identification, targeted sequence analysis (16S and 18S rRNA genes) with drug-resistance geneColorado Prior Authorization List, Pg 120 Original policy
0113UOncology (prostate), measurement of PCA3 and TMPRSS2-ERG in urine and PSA in serum following prostatic massage, by RNA amplification and fluorescence-based detection, algorithColorado Prior Authorization List, Pg 120 Original policy
0117UPain management, analysis of 11 endogenous analytes (methylmalonic acid, xanthurenic acid, homocysteine, pyroglutamic acid, vanilmandelate, 5- hydroxyindoleacetic acid, hydroxyColorado Prior Authorization List, Pg 120 Original policy
0118UTransplantation medicine, quantification of donor-derived cell-free DNA using whole genome next-generation sequencing, plasma, reported as percentage of donor-derived cell-freColorado Prior Authorization List, Pg 120 Original policy
0120UOncology (B-cell lymphoma classification), mRNA, gene expression profiling by fluorescent probe hybridization of 58 genes (45 content and 13 housekeeping genes), formalin-fixeColorado Prior Authorization List, Pg 120 Original policy
0129UHereditary breast cancer-related disorders (eg, hereditary breast cancer, hereditary ovarian cancer, hereditary endometrial cancer), genomic sequence analysis and deletion/dupColorado Prior Authorization List, Pg 120 Original policy
0130UHereditary colon cancer disorders (eg, Lynch syndrome, PTEN hamartoma syndrome, Cowden syndrome, familial adenomatosis polyposis), targeted mRNA sequence analysis panel (APCColorado Prior Authorization List, Pg 120 Original policy
0134UHereditary pan cancer (eg, hereditary breast and ovarian cancer, hereditary endometrial cancer, hereditary colorectal cancer), targeted mRNA sequence analysis panel (18 genes)Colorado Prior Authorization List, Pg 120 Original policy
0136UATM (ataxia telangiectasia mutated) (eg, ataxia telangiectasia) mRNA sequence analysis (List separately in addition to code for primary procedure)Colorado Prior Authorization List, Pg 120 Original policy
0138UBRCA1 (BRCA1, DNA repair associated), BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) mRNA sequence analysis (List separately in addition to coColorado Prior Authorization List, Pg 120 Original policy
0152UInfectious disease (bacteria, fungi, parasites, and DNA viruses), microbial cell- free DNA, plasma, untargeted next-generation sequencing, report for significant positive pathoColorado Prior Authorization List, Pg 120 Original policy
0153UOncology (breast), mRNA, gene expression profiling by next-generation sequencing of 101 genes, utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as a triplColorado Prior Authorization List, Pg 120 Original policy
0154UOncology (urothelial cancer), RNA, analysis by real-time RT-PCR of the FGFR3 (fibroblast growth factor receptor 3) gene analysis (ie, p.R248C [c.742C>T], p.S249C [c.746C>G], pColorado Prior Authorization List, Pg 120 Original policy
0155UOncology (breast cancer), DNA, PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha) (eg, breast cancer) gene analysis (ie, p.C420R, p.E542K, p.E545Colorado Prior Authorization List, Pg 120 Original policy
0156UCopy number (eg, intellectual disability, dysmorphology), sequence analysisColorado Prior Authorization List, Pg 120 Original policy
0163TTotal disc arthroplasty (artificial disc), anterior approach, including discectomy to prepare interspace (other than for decompression), each additional interspace, lumbar (LiColorado Prior Authorization List, Pg 120 Original policy
0164TRemoval of total disc arthroplasty, (artificial disc), anterior approach, each additional interspace, lumbar (List separColorado Prior Authorization List, Pg 121 Original policy
0164UGastroenterology (irritable bowel syndrome [IBS]), immunoassay for anti-CdtB and anti-vinculin antibodies, utilizing plasma, algorithm for elevated or not elevated qualitativeColorado Prior Authorization List, Pg 121 Original policy
0165TRevision including replacement of total disc arthroplasty (artificial disc), anterior approach, each additional interspaColorado Prior Authorization List, Pg 121 Original policy
0166ULiver disease, 10 biochemical assays (+2-macroglobulin, haptoglobin, apolipoprotein A1, bilirubin, GGT, ALT, AST, triglycerides, cholesterol, fasting glucose) and biometric aColorado Prior Authorization List, Pg 121 Original policy
0169UNUDT15 (nudix hydrolase 15) and TPMT (thiopurine S-methyltransferase) (eg, drug metabolism) gene analysis, common variantsColorado Prior Authorization List, Pg 121 Original policy
0170UNeurology (autism spectrum disorder [ASD]), RNA, next-generation sequencing, saliva, algorithmic analysis, and results reported as predictive probability of ASD diagnosisColorado Prior Authorization List, Pg 121 Original policy

Sources

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.